Mechanisms and management of heart failure due to diastolic dysfunction

Current Opinion in Cardiology

Volumn 11, Issue 3, 1996, Pages 269-275

  Ruzumna, Paul ^a   Gheorghiade, Mihai ^a   Bonow, Robert O ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; NITRATE;

ADRENERGIC ACTIVITY; CONNECTIVE TISSUE; ELASTICITY; HEART FAILURE; HEART LEFT VENTRICLE FILLING; HEART LEFT VENTRICLE HYPERTROPHY; HEART OUTPUT; HEART RATE; HUMAN; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SINUS RHYTHM;

EID: 0030004323     PISSN: 02684705     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001573-199605000-00007     Document Type: Review

References (54)

1. McDermott MM, Feinglass J, Sy J, Gheorghiade M: Hospitalized congestive heart failure patients with preserved versus abnormal left ventricular systolic function: clinical characteristics and drug therapy. Am J Med 1995, 99:629-635.
2. Vasan RS, Benjamin EJ, Levy D: Prevalence, clinical features and prognosis of diastolic heart failure: an epidemiologic perspective. J Am Coll Cardiol 1995, 26:1565-1574.
3. Bonow RO, Udelson JE: Left ventricular diastolic dysfunction as a cause of congestive heart failure: mechanisms and management Ann Intern Med 1992, 117:502-510.
4. Lenihan DJ, Gerson MC, Hoit BD, Walsh RA: Mechanisms, diagnosis, and treatment of diastolic heart failure. Am Heart J 1995, 130:153-166.
5. Brutsaert DL, Sys SU, Gillebert TC: Diastolic failure: pathophysiology and therapeutic implications. J Am Coll Cardiol 1993, 22:318-325.
6. Weber KT: Cardiac lnterstitium in health and disease: the flbrillar collagen network. J Am Coll Cardiol 1989, 13:1637-1652.
7. Weber KT, Janicki JS, Pick R, Abrahams C, Schroff SG, Bashey RI, Chen RM: Collagen in the hypertrophied, pressure-overloaded myocardium. Circulation 1987, 75(suppl):I-40-I-47.
8. Weber KT, Sun Y, Tyagi SC, Cleutjens JPM: Collagen network of the myocardium: function, structural remodeling and regulatory mechanisms. J Mol Cell Cardiol 1994, 26:279-292. This paper underlines that factors that contribute to the appearance of myocardial fibrosis are largely different from those that promote cardiac myocyte growth. Included among those fibrogenic factors are the effects of the renin-angiotension-aldosterone system. The importance of ACE inhibitors in the regulation of local angiotensin II and bradykinin levels and their contribution to colla-gen turnover is being reviewed.
9. Weber KT, Brilla CG: Pathological hypertrophy and cardiac interstltium: fibrosis and renin-angiotensin-aldosterone system. Circulation 1991, 83:1849-1865.
10. Fullerton MJ, Funder JW: Aldosterone and cardiac fibrosis: in vitro studies. Cardiovasc Res 1994, 28:1863-1867.
11. Kawaguchi H, Kitabatake A: Renin-angiotensin system in falling heart J Mol Cell Cardiol 1995, 27:201-209.
12. Sun Y, Weber KT: Nonendothelial ACE and myocardial fibrosls in rats receiving angiotensin II: inhibition by lisinopril [abstract]. Am J Hypertens 1993, 6:12.
13. Offstad J, Tonnessen T, Kirkeboen KA, Ilebekk A, Downing SE: Modulation of systolic and diastolic function by endothelin-1: relation to coronary flow. Acta Physiol Scand 1995, 154:103-111. This study demonstrates that in the rat, endothelin-1, when coronary flow is kept constant, causes a progressive increase in left ventricular stiffness. The mechanism beyond the endothelin-1 inducing increase in left ventricular end diastolic pressure is unknown.
14. Bonow RO, Kent KM, Rosing DR, et al.: Improved left ventricular diastolic filling in patients with coronary angioplasty. Circulation 1982, 66:1159-1167.
15. Gorcsan J, Diana P, Lee J, Karz WE, Hattler BG: Reversible diastolic dysfunction after successful coronary artery bypass surgery: assessment by transesophageal Doppler echocardiography. Chest 1994, 106:1364-1369.
16. Nayler WG, Williams A: Relaxation in heart muscle: some morphologic and biochemical considerations. Eur J Cardiol 1978, 7(suppl):35-50.
17. Nayler WG, Poole-Wilson PA, Williams A: Hypoxia and calcium. J Mol Cell Cardiol 1979, 11:683-706.
18. Aroesty JM, McKay RG, Heller GV, Royal HD, Als AV, Grossman W: Simultaneous assessment of left ventricular systolic and diastolic dysfunction during pacing induced ischemia. Circulation 1985, 71:889-900.
19. Cargill RI, Kiely DG, Lipworth BJ: Adverse effects of hypoxaemia on diastolic filling in humans. Clin Sci 1995, 89:165-169.
20. Wheeldon NM, Clarkson P, MacDonald TM: Diastolic heart failure. Eur Heart J 1994, 15:1689-1697.
21. Shapiro LM, Gibson DG: Patterns of diastolic dysfunction in left ventricular hypertrophy. Br Heart J 1988, 39:438-445.
22. Rozich JD, Barnes MA, Schmid PG, Zile MR, McDermott PJ, Cooper G: Load effects on gene expression during cardiac hypertrophy. J Mol Cell Cardiol 1995, 27:485-499. This paper examines the effects of loading conditions on gene expression during cardiac hypertrophy.
23. Hunter JJ, Tanaka N, Rockman HA, Ross J, Chien KR: Ventricular expression of a MLC-2v-ras fusion gene induces cardiac hypertrophy and selective diastolic dysfunction in transgenic mice. J Biol Chem 1995, 270:2173-2178.
24. Naqvi RU, Macleod KT: Effect of hypertrophy on mechanisms of relaxation in isolated cardiac myocytes from guinea pig. Am J Physiol 1994, 267(Heart Circ Physiol 36):H1851-H1861.
25. Baudet S, Noireaud J, Leoty C: Effect of hemodynamic pressure overload of the adult ferret right ventricle on inotropic responsiveness to external calcium and rest periods. Pfluegers Arch 1992, 420:603-610.
26. Sobue T, Yokota M, Iwase M, Ishihara H: Influence of left ventricular hypertrophy on left ventricular function during dynamic exercise in the presence or absence of coronary artery disease. J Am Coll Cardiol 1995, 25:91-98.
27. Clarkson PBM, Wheeldon NM, Macleod C, MacDonald TM: Systolic and diastolic effects of β-adrenergic stimulation in normal humans. Am J Cardiol 1995, 75:206-209. This study examines the hypothesis that in normal humans β-adrenoreceptor stimulation with isoprenaline has affects on myocardial relaxation at doses that have no effect on chronotropic or inotropic responses.
28. Clarkson PBM, Wheeldon NM, Macleod C, Coutie W, MacDonald TM: Brain natriuretic peptide: effect on left ventricular filling patterns in healthy subjects. Clin Sci 1995, 88:159-164.
29. Lang CC, Prasad N, McAlpine HM, Macleod C, Lipworth BJ, MacDonald TM, Struthers AD: Increased plasma levels of brain natriuretic peptide in patients with isolated diastolic dysfunction. Am Heart J 1994, 127:1635-1636.
30. Hasebe N, Hittinger L, Kohin S, Shen YT, Graham RM, Vatner SF: Effects of hypertrophy on left atrial and ventricular compliance and plasma ANF levels in conscious dogs. Am J Physiol 1995, 268(Heart Circ Physiol 37):H781-H787.
31. Pontremoli R, Bezante GP, Robaudo C: Cardiac diastolic abnormalities and atrial natriuretic factor in essential hypertension. Eur Heart J 1993, 14:910-914.
32. Lakatta EG, Yin FC: Myocardial aging: function alterations and related cellular mechanisms. Am J Physiol 1982, 242:H927-H941.
33. Capasso JM, Malhotra A, Remily RM, Scheuer J, Sonnenblick EH: Effects of age on mechanical and electrical performance of rat myocardium. Am J Physiol 1983, 245:H72-H81.
34. Marantz PR, Tobin JN, Derby CA, Cohen MV: Age-associated changes in diastolic filling: Doppler E/A ratio is not associated with congestive heart failure in the elderly. South Med J 1994, 87:728-735.
35. Mantero A, Gentile F, Gualtierotti C, Azzollini M, Barbier P, Beretta L, Casazza F, Corno R, Giagnoni E, Lippolis A, et al.: Left ventricular diastolic parameters in 288 normal subjects from 20 to 80 years old. Eur Heart J 1995, 16:94-105.
36. Fleg JL, Schulman S, O'Connor F, Becker LC, Gerstenblith G, Clulow JF, Renlund DG, Lakatta EG: Effects of acute β-adrenergic receptor blockade on age-associated changes in cardiovascular performance during dynamic exercise. Circulation 1994, 90:2333-2341. This paper suggests that the age-associated decline in maximal heart rate in left ventricular contractility during exercise is the manifestation of reduced β-adrenergic responsiveness with advanced age.
37. White M, Leenen FHH: Aging and cardiovascular responsiveness to β-agonist in humans: role of changes in β-receptor responses versus baroreflex activity. Clin Pharmacol Ther 1994, 56:543-553.
38. Santos AD, Miller RP, Mathew P, et al.: Echocardiographic characterization of the reversible cardiomyopathy of hypothyroidism. Am J Med 1980, 68:675-682.
39. Grossman G, Wieshammer S, Keck FS, Goeller V, Giesler M, Hombach V: Doppler echocardiographic evaluation of left ventricular diastolic function in acute hypothyroidism. Clin Endocrinol 1994, 40:227-233.
40. Committee on Evaluation and Management of Heart Failure: Guidelines for the evaluation and management of heart failure: report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 1995, 26:1376-1398. The American College of Cardiology and the American Heart Association developed practice guidelines for evaluation and management of heart failure that include patients with diastolic heart failure.
41. Elkayam U, Shotan A, Mehra A, Ostrzega E: Calcium channel blockers in heart failure. J Am Coll Cardiol 1993, 22(suppl): 139A-144A.
42. Arrighi JA, Dilsizian V, Perrone-Filardi P, Diodati JG, Bacharach SL, Bonow RO: Improvement of the age related impairment in left ventricular diastolic filling with verapamil in the normal human heart Circulation 1994, 90:213-219. Verapamil appears to selectively enhance left ventricular diastolic filling in elderly subjects compared with young adults, without affecting systolic function. It appears that impaired left ventricular filling that is associated with the normal aging process may be reversible.
43. Cheng CP, Pettersson K, Little WC: Effects of felodipine on ten ventricular systolic and dlastolic performance in congestive heart failure. J Pharmacol Exp Ther 1994, 271:1409-1417.
44. Weinberg EO, Schoen FJ, George D, Kagaya Y, Douglas PS, Litwink SE, Schunkert H, Benedict CR, Lorell BH: Angiotensin-converting enzyme Inhibition prolongs survival and modifies the transition to heart failure in rats with pressure overload hypertrophy due to ascending aortic stenosis. Circulation 1994, 90:1410-1422.
45. Friedrich SP, Lorell BH, Rousseau MF, Hayashida W, Hess OM, Douglas PS, Gordon S, Keighley CS, Benedict C, Krayenbuehl HP, et al.: Intracardiac angiotensin-converting enzyme inhibition improves diastolic function in patients with left ventricular hypertrophy due to aortic stenosis. Circulation 1994, 90:2761-2771.
46. Marian AJ, Roberts R: Recent advances in the molecular genetics of hypertrophic cardiomyopathy. Circulation 1995, 92:1336-1347. This excellent review attempts to elucidate the molecular basis of hypertrophic cardiomyopathy, which may lead to better understanding of its pathophysiology and will be likely to provide a better therapeutic approach.
47. Belardinelli R, Georgiou D, Cianci G, Berman N, Ginzton L, Purcaro A: Exercise training improves left ventricular diastolic filling in patients with dilated cardiomyopathy: clinical and prognostic implications. Circulation 1995, 91:2775-2784.
48. Ammar A, Wong M, Singh BN: Divergent effects of chronic amiodarone administration on systolic and diastolic function in patients with heart disease. Am J Cardiol 1995, 75:465-469.
49. Carroll JO, Lang RM, Neumann AL, Borow KM, Rajfer SI: The differential effects of positive inotropic and vasodilator therapy on diastolic properties in patients with congestive cardiomyopathy. Circulation 1986, 74:815-825.
50. Monrad ES, McKay RG, Baim DA, et al.: Improvement in Indexes of diastolic performance in patients with congestive heart failure treated with mllrinone. Circulation 1984, 70:1030-1037.
51. Pouleur H, Rousseau MF, Hanet C, Mariow HF, Charter AA: Left ventricular sensitivity to β-adrenoceptor-stimulating drugs in patients with ischemic heart disease and varying degrees of ventricular function. Circ Res 1987, 61(suppl):91-95.
52. Stampfer M, Epstein SE, Beiser GD, Braunwald E: Hemodynamic effects of diuresis at rest and during intense upright exercise in patients with impaired cardiac function. Circulation 1968, 37:900-911.
53. Smith ER, Smiseth OA, Knigma I, Manyari D, Belenkie I, Tyberg JV: Mechanism of action of nitrates: role of changes in venous capacitance and in the left ventricular diastolic pressure-volume relation. Am J Med 1984, 76A: 14-21.
54. Grocott-Mason R, Anning P, Evans H, Lewis MJ, Shah AM: Modulation of left ventricular relaxation in isolated ejecting heart by endogenous nitric oxide. Am J Physiol 1994, 267(Heart Circ Physiol 36):H1804-H1813. This paper suggests that endogenous nitric oxide modulates left ventricular relaxation in the intact heart.